Amer M. Zeidan
0000-0001-7017-8160
4 papers found
Refreshing results…
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists
Updates on risk stratification and management of lower-risk myelodysplastic syndromes/neoplasms
Considerations for Drug Development in Myelodysplastic Syndromes
TP53 ‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity
Missing publications? Search for publications with a matching author name.